Michael Mirabella
Lawyers
Filters
Olema Pharmaceuticals $150 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Amneal Pharmaceuticals $2.35 billion term loan
We advised Amneal Pharmaceuticals on a new term loan
Harvest Partners $5.34 billion fundraise for its ninth flagship PE fund
We advised Harvest Partners on the fundraise
Genuine Parts Company $800 million senior notes offering
The investment-grade notes are due 2028 and 2033
CSX $600 million senior notes offering
We advised CSX on the investment-grade debt offering
Travelers $750 million senior notes offering
The investment-grade notes are due 2053
Olema Pharmaceuticals $100 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Bowlero $900 million term loan refinancing and $35 million revolver increase
We advised the borrower on the transaction
Precigen $75 million follow-on offering
We advised Precigen on the SEC-registered offering
Deutsche Bank $1.5 billion notes offering
The fixed-to-floating-rate eligible liabilities senior notes are due 2029